BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ishimura N, Kinoshita Y. Eosinophilic esophagitis in Japan: Focus on response to acid suppressive therapy: Eosinophilic esophagitis in Japan. Journal of Gastroenterology and Hepatology 2018;33:1016-22. [DOI: 10.1111/jgh.14079] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Kanamori A, Tanaka F, Takashima S, Sawada A, Ominami M, Nadatani Y, Fukunaga S, Otani K, Hosomi S, Kamata N, Nagami Y, Taira K, Watanabe T, Fujiwara Y. Esophageal mast cells may be associated with the perception of symptoms in patients with eosinophilic esophagitis. Esophagus 2022. [DOI: 10.1007/s10388-022-00967-w] [Reference Citation Analysis]
2 Goda K, Abe K, Kanamori A, Kondo M, Kojimahara S, Kanazawa M, Tanaka T, Nagashima K, Suzuki T, Yamamiya A, Hoshi K, Tominaga K, Majima Y, Iijima M, Irisawa A. Advanced Endoscopy for Benign Esophageal Disease: A Review Focused on Non-Erosive Reflux Disease and Eosinophilic Esophagitis. Healthcare 2022;10:2183. [DOI: 10.3390/healthcare10112183] [Reference Citation Analysis]
3 Okimoto E, Ishimura N, Adachi K, Kinoshita Y, Ishihara S, Tada T. Application of Convolutional Neural Networks for Diagnosis of Eosinophilic Esophagitis Based on Endoscopic Imaging. JCM 2022;11:2529. [DOI: 10.3390/jcm11092529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Tamarit-sebastian S, Ferrer-soler FM, Lucendo AJ. Current options and investigational drugs for the treatment of eosinophilic esophagitis. Expert Opinion on Investigational Drugs. [DOI: 10.1080/13543784.2022.2033207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Manabe N, Todo E, Haruma K, Ayaki M, Nakamura J, Fujita M, Monobe Y, Kato K, Kamada T, Handa Y, Matsubara M, Yamatsuji T, Naomoto Y. A case of eosinophilic gastroenteritis with high PET-CT accumulation treated by P-CAB. Radiol Case Rep 2021;16:2174-8. [PMID: 34168718 DOI: 10.1016/j.radcr.2021.05.039] [Reference Citation Analysis]
6 Odiase E, Zhang X, Chang Y, Nelson M, Balaji U, Gu J, Zhang Q, Pan Z, Spechler SJ, Souza RF. In Esophageal Squamous Cells From Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion Through Effects on Intracellular Calcium and a Non-Gastric Proton Pump. Gastroenterology 2021;160:2072-2088.e6. [PMID: 33581123 DOI: 10.1053/j.gastro.2021.02.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
7 Nagahara A, Shiotani A, Iijima K, Kamada T, Fujiwara Y, Kasugai K, Kato M, Higuchi K. The role of advanced endoscopy in the management of inflammatory digestive diseases (upper gastrointestinal tract). Dig Endosc 2021. [PMID: 33772880 DOI: 10.1111/den.13982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Scarpignato C, Hunt RH. Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers. Curr Treat Options Gastro 2021;19:94-132. [DOI: 10.1007/s11938-020-00330-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Tanaka T, Watanabe N, Kato T, Aoki R, Ogiso T, Sugiyama A, Tomita E. Utility of Direct Fast Scarlet Staining in the Histopathological Diagnosis of Eosinophilic Esophagitis: A Short Report. GastrointestDisord 2020;2:448-55. [DOI: 10.3390/gidisord2040040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Ishimura N, Okimoto E, Shibagaki K, Nagano N, Ishihara S. Similarity and difference in the characteristics of eosinophilic esophagitis between Western countries and Japan. Dig Endosc 2021;33:708-19. [PMID: 32623781 DOI: 10.1111/den.13786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Fujiwara Y. Symptom-based diagnostic approach for eosinophilic esophagitis. J Gastroenterol 2020;55:833-45. [PMID: 32720208 DOI: 10.1007/s00535-020-01701-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Imamura K, Haruma K, Matsumoto H, Maruyama Y, Ayaki M, Tazaki S, Hisamoto N, Manabe N, Kamada T, Kawamoto H. Clinical and endoscopic characteristics of eosinophilic esophagitis in Japan: a case-control study. Asia Pac Allergy 2020;10:e16. [PMID: 32411581 DOI: 10.5415/apallergy.2020.10.e16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Sato H, Honma T, Nozawa Y, Owaki T, Imai M, Sano T, Iwanaga A, Seki K, Ishikawa T, Yoshida T, Terai S. Eosinophilic esophagitis in Japanese patients: A mild and slow-progressing disorder. PLoS One 2018;13:e0206621. [PMID: 30388148 DOI: 10.1371/journal.pone.0206621] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
14 Ishimura N, Sumi S, Okada M, Mikami H, Okimoto E, Nagano N, Araki A, Tamagawa Y, Mishiro T, Oshima N, Ishihara S, Maruyama R, Kinoshita Y. Is Asymptomatic Esophageal Eosinophilia the Same Disease Entity as Eosinophilic Esophagitis? Clin Gastroenterol Hepatol 2019;17:1405-7. [PMID: 30144524 DOI: 10.1016/j.cgh.2018.08.048] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]